您当前的位置:
首页 >
文章列表页 >
Evaluation synergism of GLS/IL-12 recombinant M.s megmatis to anti-tuberculosis chemotherapy in murine model of M.tuberculosis infection
更新时间:2024-01-17
    • Evaluation synergism of GLS/IL-12 recombinant M.s megmatis to anti-tuberculosis chemotherapy in murine model of M.tuberculosis infection

    • Journal of Chongqing Medical University   Vol. 34, Issue 5, Pages: 516-520(2009)
    • 作者机构:

      1. 重庆医科大学基础医学院免疫学教研室

      2. 重庆医科大学基础医学院神经科学研究中心

      3. 重庆医科大学基础医学院病原生物学教研室

    • CLC: R52
    • Published:2009,

    扫 描 看 全 文

  • YANG Xiao-yan, et al. Evaluation synergism of GLS/IL-12 recombinant M.s megmatis to anti-tuberculosis chemotherapy in murine model of M.tuberculosis infection. [J]. Journal of Chongqing Medical University 34(5):516-520(2009) DOI:

  •  
  •  

0

Views

46

下载量

2

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Construction and identification of the chimeric mtb8.4/hIL12 eukaryotic expression plasmid
The cDNA cloning of human granulysin Mr 15000 and Mr 9000 active segments from CTL activated by allogenic antigen
The distribution and expression of recombinant M.smegmatis in mice receiving intranasal immunization
Qualitative study about how to improve treatment adherence of patients with Tuberculosis
Association of IL-18 promoter polymorphisms with susceptibility to tuberculosis and its protein production in Chongqing Han children

Related Author

任红
钟森
et al
LI Hui
刘晔华
何永林
杨春
et al

Related Institution

重庆医科大学第二临床学院感染科
泸州医学院附属医院感染病科
Department of Infectious Disease,the Second College of Clinical Medicine,Chongqing Medical University
重庆医科大学基础医学院微生物学与免疫学教研室
0